analyst
VC
NASDAQ · VCEL
Vericel Corporation
Healthcare · Biotechnology
$39.71
Up+$0.41 (+1.04%)
Updated Sep 27, 2026, 12:19 PM
SID Score
4.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.89B
- P/E ratio
- 144.38
- Dividend yield
- 0.00%
- 52-week range
- $28.95 – $49.32
- Volume
- 359.9K
- Avg. volume
- 728.95K
Price performance
VCEL price history
1M range · 19 trading sessions · Daily adjusted prices
VCEL closed at $39.71 after 19 trading sessions, down 0.48% for the selected period.
- Last close
- $39.71
- Period change
- -0.48%
- Period low
- $37.87
- Period high
- $40.89
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 25, 2026 | $39.30 | $39.80 | $38.735 | $39.71 | 359.9K |
| Sep 24, 2026 | $38.86 | $39.40 | $38.385 | $39.30 | 351.98K |
| Sep 23, 2026 | $39.95 | $40.10 | $38.21 | $38.79 | 433.96K |
| Sep 22, 2026 | $40.00 | $40.4154 | $39.55 | $40.22 | 546.96K |
| Sep 21, 2026 | $40.08 | $40.29 | $39.05 | $39.55 | 402.18K |
| Sep 18, 2026 | $39.80 | $40.21 | $39.565 | $40.02 | 1.13M |
| Sep 17, 2026 | $40.62 | $40.62 | $39.06 | $40.03 | 536.42K |
| Sep 16, 2026 | $39.73 | $40.87 | $39.725 | $40.21 | 490.48K |
| Sep 15, 2026 | $39.39 | $40.145 | $38.545 | $39.72 | 654.83K |
| Sep 14, 2026 | $38.58 | $39.70 | $38.20 | $39.60 | 629.43K |
| Sep 11, 2026 | $38.39 | $38.945 | $37.35 | $38.34 | 503.53K |
| Sep 10, 2026 | $38.56 | $38.815 | $37.672 | $37.87 | 340.24K |
| Sep 9, 2026 | $38.72 | $39.19 | $38.53 | $38.99 | 366.52K |
| Sep 8, 2026 | $39.69 | $39.72 | $38.74 | $39.08 | 410.3K |
| Sep 4, 2026 | $40.04 | $40.57 | $39.85 | $40.19 | 312.91K |
| Sep 3, 2026 | $41.30 | $41.30 | $40.085 | $40.47 | 301.27K |
| Sep 2, 2026 | $40.49 | $41.49 | $40.35 | $40.89 | 395.53K |
| Sep 1, 2026 | $39.87 | $41.435 | $39.655 | $40.50 | 651.11K |
| Aug 31, 2026 | $40.48 | $40.8808 | $39.34 | $39.90 | 636.31K |
Latest VCEL news
The latest Smart Investors Daily articles mentioning VCEL.
Stock researchCompany · Forecast
Loading stock research…